JUNS vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

JUNS

55.1
AI Score
VS
JUNS Wins

CLYM

41.4
AI Score

Investment Advisor Scores

JUNS

55score
Recommendation
HOLD

CLYM

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric JUNS CLYM Winner
Net Income -8.64M -27.22M JUNS
Operating Income -8.91M -30.57M JUNS
ROE 471.9% -11.4% JUNS
ROA -155.4% -11.1% CLYM
Total Assets 5.56M 246.29M CLYM
Cash 3.79M 44.11M CLYM
Current Ratio 0.65 31.45 CLYM

Relative Price Performance (Last 90 Days)

JUNS 1M: -33.8% · 3M: +1231.9% CLYM 1M: -1.0% · 3M: +30.6%

Current Technical Phase

JUNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.2 · Price: $3.05

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $14.25

Fundamentals Snapshot

Metric JUNS CLYM
Market Cap
Forward P/E 50.8 -14.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin -28.1%
Operating Margin -113.1% 0.0%
EPS -19.06 -0.82
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, JUNS is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.